Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy INC Research stock
Learn how to easily invest in INC Research stock.
INC Research Holdings Inc is a diagnostics & research business based in the US. INC Research shares (SYNH) are listed on the NASDAQ and all prices are listed in US Dollars. INC Research employs 26,751 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in INC Research
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SYNH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
INC Research stock price (NASDAQ: SYNH)Use our graph to track the performance of SYNH stocks over time.
INC Research shares at a glance
|Latest market close||$71.57|
|52-week range||$62.28 - $104.18|
|50-day moving average||$70.87|
|200-day moving average||$85.09|
|Wall St. target price||$93.90|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$2.31|
Buy INC Research shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy INC Research stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
INC Research price performance over time
|1 week (2022-06-28)||0.14%|
|1 month (2022-06-01)||-0.82%|
|3 months (2022-04-05)||-12.19%|
|6 months (2022-01-05)||-23.71%|
|1 year (2021-07-02)||-20.03%|
|2 years (2020-07-02)||24.40%|
|3 years (2019-07-05)||41.28%|
|5 years (2017-07-05)||24.42%|
Is INC Research stock undervalued or overvalued?
Valuing INC Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of INC Research's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
INC Research's P/E ratio
INC Research's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, INC Research shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
INC Research's PEG ratio
INC Research's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1872. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into INC Research's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
INC Research's EBITDA
INC Research's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $673.2 million.
The EBITDA is a measure of a INC Research's overall financial performance and is widely used to measure a its profitability.
INC Research financials
|Revenue TTM||$5.3 billion|
|Operating margin TTM||8.11%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||3.33%|
|Return on equity TTM||7.41%|
|Market capitalisation||$7.3 billion|
TTM: trailing 12 months
INC Research share dividends
We're not expecting INC Research to pay a dividend over the next 12 months.
INC Research share price volatility
Over the last 12 months, INC Research's shares have ranged in value from as little as $62.28 up to $104.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INC Research's is 1.7868. This would suggest that INC Research's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
INC Research overview
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc.
INC Research in the news
Syneos Health (SYNH) is a Top-Ranked Growth Stock: Should You Buy?
Here's Why Investors Should Retain Syneos Health (SYNH) For Now
Executive Voice: She's in charge now at $5B Morrisville firm Syneos Health
Frequently asked questionsWhat percentage of INC Research is owned by insiders or institutions?
Currently 0.432% of INC Research shares are held by insiders and 98.952% by institutions. How many people work for INC Research?
Latest data suggests 26,751 work at INC Research. When does the fiscal year end for INC Research?
INC Research's fiscal year ends in December. Where is INC Research based?
INC Research's address is: 1030 Sync Street, Morrisville, NC, United States, 27560-5468 What is INC Research's ISIN number?
INC Research's international securities identification number is: US87166B1026 What is INC Research's CUSIP number?
INC Research's Committee on Uniform Securities Identification Procedures number is: 45329R109
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert